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Abstract
Objective. Obesity is associated with insulin resistance and type 2 diabetes, although the
mechanisms linking these pathologies remain undetermined. Recent studies in rodent models
revealed endoplasmic reticulum (ER) stress in adipose and liver tissues and demonstrated that
ER stress could cause insulin resistance. Therefore, we tested whether these stress pathways
were also present in obese human subjects and/or regulated by weight loss.
Research Design and Methods. Eleven obese men and women (BMI: 51.3 ± 3.0 kg/m2) were
studied before and 1 year after gastric bypass (GBP) surgery. We examined systemic insulin
sensitivity using hyperinsulinemic-euglycemic clamp studies before and after surgery and
collected subcutaneous adipose and liver tissues to examine ER stress markers.
Results. Subjects lost 39 9% body weight at 1 year after GBP surgery (p<0.001), which was
associated with a marked improvement in hepatic, skeletal muscle and adipose tissue insulin
sensitivity. Markers of ER stress in adipose tissue significantly decreased with weight loss.
Specifically, Grp78 and spliced XBP-1 mRNA levels were reduced, as were phosphorylated
eIF2

and stress kinase JNK1 (all p values <0.05). Liver sections from a subset of subjects

showed intense staining for Grp78 and phosphorylated eIF2 before surgery, which was reduced
in post-GBP sections.
Conclusions. This study presents important evidence that ER stress pathways are present in
selected tissues of obese humans, and that these signals are regulated by marked weight loss and
metabolic improvement. Hence, this suggests the possibility of an integral relationship between
obesity-related ER stress and metabolic dysfunction in obese humans.

Introduction
Increased adiposity is associated with a group of chronic metabolic disorders, including insulin
resistance, type 2 diabetes, and nonalcoholic fatty liver disease [1]. The prevalence of this
cluster of abnormalities has increased significantly in the past few decades following the marked
rise of obesity worldwide [2, 3]. The mechanisms responsible for the emergence of these
disorders have been an intense area of investigation. In the past decade it was recognized and
established that chronic inflammatory and stress responses are a central feature of obesity,
insulin resistance, and type 2 diabetes and contribute to the metabolic imbalance [4]. However,
the pathways and mechanisms giving rise to the chronic inflammatory responses remain to be
elucidated.

Recently, we have identified endoplasmic reticulum (ER) dysfunction as a significant contributor
to the development of experimental insulin resistance in obese tissues [5]. The ER is a critical
intracellular organelle that coordinates the synthesis, folding, and trafficking of proteins. All
transmembrane and secreted proteins pass through the ER en route to cellular destinations;
proteins that fail to fold into proper structures are removed from the ER through degradation.
Under stress conditions, unfolded proteins accumulate in the ER and initiate an adaptive
response known as the unfolded protein response (UPR). The UPR is initiated by three ER
transmembrane sensors (namely PERK (PKR-like ER-regulated kinase), IRE-1 (inositolrequiring enzyme-1), and ATF-6 (activating transcription factor-6) which activate an adaptive
response that results in cessation of protein translation and transcriptional increase in proteinfolding chaperones and ER-associated degradation genes [6]. If the stress is too severe, the UPR
may also induce cellular apoptosis through several different mechanisms involving the various

branches of the UPR. In mouse models of obesity, ER stress is present in liver and adipose
tissues, as evidenced by increased activity of both the IRE-1 and PERK branches [7]. The UPR
is also able to induce activation of the JNK pathway and thereby inhibit insulin signaling through
the subsequent phosphorylation and/or degradation of IRS1 [7-9]. Data obtained from mouse
models demonstrate that genetically compromised ER folding capacity induces ER stress,
activates JNK and leads to whole body insulin resistance in the mouse [7].

In contrast,

enhancing ER capacity in obese mice through the use of chemical or molecular chaperones
relieves ER stress in adipose tissue and liver, reduces intrahepatic fat accumulation, and restores
glucose homeostasis [10].

Although ER stress is associated with obesity and metabolic dysfunction in rodent models, the
importance of ER stress in the pathogenesis of obesity-related metabolic disease and the
potential regulation of ER function by weight loss in human subjects is not known. Therefore,
the purpose of the present study was to evaluate the effect of marked weight loss induced by
gastric bypass (GBP) surgery, on insulin sensitivity and ER stress in key metabolic tissues in
obese human subjects. A euglycemic-hyperinsulinemic clamp procedure, in conjunction with
stable isotopically labeled tracer infusions, was used to assess insulin action in liver, skeletal
muscle and adipose tissue, and UPR markers from among the three response branches were
evaluated in liver and adipose tissue samples obtained before and 1 year after GBP surgery.

Research Design and Methods
Subjects and Gastric bypass surgery
Eleven obese subjects (mean BMI: 51.3 ± 3.0 kg/m2; 2 men and 9 women) who were scheduled
to undergo GBP surgery participated in this study. All subjects completed a comprehensive
medical evaluation, which included a detailed history and physical examination, routine blood
tests, and a 12-lead electrocardiogram. No subjects had diabetes, other metabolic diseases, or
were taking medications that affect insulin action or glucose and fatty acid metabolism. All
subjects gave their written informed consent before participating in this study, which was
approved by the Human Research Protection Office and the Center for Applied Research
Sciences Advisory Committee of Washington University School of Medicine in St. Louis, MO.

All GBP procedures were performed by the same surgeon (J.C.E.) using standard surgical
techniques. All patients had an open GBP procedure, which involved constructing a small (~20
mL) proximal gastric pouch by stapling across the stomach. A 150 cm Roux-Y limb was
constructed by transecting the jejunum 30 cm distal to the ligament of Treitz and creating a
jejunojejunostomy 150 cm distal to the transection.

Metabolic Studies and Sample Analyses
Insulin sensitivity was examined by using the hyperinsulinemic-euglycemic clamp procedure in
10 of the 11 subjects before and one year after GBP surgery. Subjects were admitted to the
Intensive Research Unit at Washington University School of Medicine on the evening before the
clamp procedure.

The following morning, after subjects fasted overnight, a one-stage

hyperinsulinemic-euglycemic clamp procedure was performed;

[6,6-2H2]glucose and [2,2-

2

H2]palmitate were infused for 6 hours (0-3 h basal period followed by 3-6 h insulin infusion at a

rate of 15 mU·m-2 body surface area [BSA]·min-1, initiated with a priming dose of 60 mU·m-2
BSA·min-1 for 5 min, and then 30 mU·m-2 BSA·min-1 for 5 min. Euglycemia was maintained at a
blood glucose concentration of approximately 5.6 mmol/L (100 mg/dL) throughout the clamp
procedure by infusing 20% dextrose enriched to 2.5% with [6,6-2H2]glucose. Blood samples
were obtained before beginning the tracer infusion to determine background plasma glucose and
palmitate tracer-to-tracee ratios (TTRs), and every 10 min during the final 30 min of the basal
period and of the clamp procedure to determine glucose, and insulin concentrations and substrate
kinetics.

Plasma insulin was determined by a radioimmunoassay and plasma glucose and

palmitate tracer to tracee ratios were determined by using gas chromatography-mass
spectroscopy (GC-MS; MSD 5973 system with capillary column; Hewlett-Packard; Palo Alto,
CA), as previously described [11, 12]. Glucose and palmitate kinetics were determined by using
Steele’s equation for steady-state conditions [13, 14] and hepatic insulin sensitivity was
determined by the reciprocal of the Hepatic Insulin Resistance Index (10000/(basal glucose Ra in
µmol/kg/min X basal insulin concentration in mU/L), as previously described [15, 16].

Subcutaneous abdominal adipose tissue samples were collected during basal postabsorptive
conditions in all subjects by using a 14-gauge needle; samples were immediately frozen in liquid
nitrogen. Liver tissue samples were obtained by needle biopsy during GBP surgery and by
percutaneous needle biopsy 1 year after GBP surgery in 4 subjects, and placed in formalin for
further analyses.

mRNA Isolation and quantitative PCR
Frozen adipose tissue samples were homogenized in TRIzol Reagent (Invitrogen) for total RNA
isolation according to the manufacturer’s protocol. cDNA synthesis was performed using 1 µg
of sample RNA reverse transcribed with the high capacity cDNA archive system (Applied
Biosystems, Foster City, CA). Real-time, quantitative PCR was performed using SybrGreen
reagent in the ABI 7300 Real-Time PCR system (Applied Biosystems) to determine the mRNA
levels of the following genes in adipose tissue samples obtained before and after gastric by-pass
surgery: 18S, CHOP, sXBP, Grp78, and IL-6. Primer sequences used to detect these human
genes are listed below.
hu 18S For

GTAACCCGTTGAACCCCATT

hu 18S Rev

CCATCCAATCGGTAGTAGCG

hu Grp78 For

CATCACGCCGTCCTATGTCG

hu Grp78 Rev

CGTCAAAGACCGTGTTCTCG

hu sXBP For

GGTCTGCTGAGTCCGCAGCAGG

hu sXBP Rev

GGGCTTGGTATATATGTGG

hu CHOP For

GGAGAACCAGGAAACGGAAAC

hu CHOP Rev

TCTCCTTCATGCGCTGCTTT

hu IL-6 For

AAATTCGGTACATCCTCGACGG

hu IL-6 Rev

GGAAGGTTCAGGTTGTTTTCTGC

Protein Isolation, antibodies and Western blotting
Frozen adipose tissue samples were homogenized in lysis buffer containing 25 mM Tris-HCl
(pH7.4), 10 mM Na3VO4, 100 mM NaF, 50 mM Na4P2O7, 10 mM EGTA, 10 mM EDTA, 1%
NP-40 with protease inhibitors (Sigma). After homogenization, the tissue lysate was centrifuged
at 4,000 rpm for 15 minutes at 4°C followed by 14,000 rpm for 20 mins at 4°C. Eighty µg total
tissue protein was used for direct immunoblotting. Rabbit polyclonal anti-p-eIF2 antibody
(Invitrogen, #44728G) was used at 1:1000 dilution; mouse monoclonal anti-p-JNK (Cell

Signaling, #9251) was used at 1:1000 dilution; rabbit polyclonal anti-calnexin (Stressgen) was
used at 1:1000 dilution; -tubulin (Santa Cruz, #8104) was used at 1:1000 dilution. Horseradish
peroxidase (HRP)-linked anti-mouse, or anti-rabbit secondary antibody (GE Healthcare) was
used at 1:4000 dilution.

Immunohistochemical examination of liver sections
Liver biopsy specimens were evaluated for steatosis and inflammation by hematoxylin and eosin
staining and for markers of ER stress by using immunohistochemistry. Human liver sections
were subjected to routine deparafinization/hydration process and blocked with goat serum
albumin for 1 hour at room temperature. Primary antibody incubation at 1:50 concentration was
performed overnight at 4oC. After primary antibody incubation, sections were washed with PBS,
and incubated with secondary antibody at 1:200 dilution for 60 minutes. At the end of the
secondary antibody incubation sections were washed with PBS followed by application of
mounting solution containing DAPI (Vector Lab). Secondary antibodies used in the current study
were FITC- or texas-red conjugated anti-rabbit IgG (Santa Cruz). Negative controls included
omission of the primary antibody.

Quantification of immunohistochemical staining was

performed using Axiovision Software and is represented as relative intensity of 6-9 areas per
slide.

Selection of UPR markers
We chose UPR markers from among the three branches that respond to ER stress. The
transmembrane kinase PERK phosphorylates eukaryotic elongation initiation factor 2 (eIF2 ),
leading to inhibition of general protein translation. As a result of alternative translation, the proapoptotic transcription factor C/EBP homologous protein (CHOP) is induced. IRE-1 activates

the stress kinase c-jun N-terminal kinase1 (JNK1) and also possesses endoribonuclease activity,
which splices an intron from the mRNA of X-box binding protein-1 (XBP-1), creating an
activated transcription factor. Spliced XBP-1 (sXBP-1), along with active ATF-6, translocates to
the nucleus and induces expression of protein chaperone genes. One well-known target of both
of these transcription factors is the chaperone glucose-regulated protein 78 (Grp78).

Statistical analyses
Insulin sensitivity and patient information data sets were normally distributed according to the
Kolmogorov-Smirnov test, so that comparisons between subjects before and after weight loss
were performed using parametric procedures. The statistical significance of the effect of insulin
infusion on substrate metabolism before and after weight loss was analyzed by using the
Student’s t-test for paired samples. Results are presented as means ±SEM. All reported p-values
are two-sided, and a p-value of <0.05 was considered to be statistically significant.

Results

Study subject characteristics and insulin sensitivity
On average, subjects lost ~40% of their initial body weight at 1 year after GBP surgery (Table
1). Weight loss caused a marked decrease in plasma glucose and insulin concentrations and in
intrahepatic fat content (Table 1). The Hepatic Insulin Sensitivity Index (HISI) value was 160%
greater 1 year after than before GBP surgery (p<0.01) (Figure 1A). Insulin infusion during the
clamp procedure increased plasma insulin concentration from 18.7±3.1to 43.6±4.2 mU/L before
and from 4.9±0.8 to 27.0±1.5 mU/L 1 year after GBP surgery. Plasma glucose concentration
during insulin infusion were 97.7±1.7 and 99.6±1.9 mg/dL during the clamp procedure
performed before and after weight loss, respectively. Insulin infusion caused an increase in
glucose Rd from 1081±69 to 1418±108 µmol/min before GBP surgery and from 813±57 to
1666±171 µmol/min 1 year after GBP surgery. The increase in glucose Rd during insulin
infusion was 200% greater after than before weight loss (p<0.01) (Figure 1B). Insulin infusion
caused a decrease in palmitate Ra from 161±13 µmol/ min to 61±14 µmol/min before GBP
surgery and from 105±9 to 21±4 µmol/min 1 year after GBP surgery. Insulin-mediated
suppression of palmitate Ra was 23% greater 1 year after than before weight loss (p<0.01)
(Figure 1C). Taken together these data demonstrate marked metabolic improvement in subjects
following weight reduction by GBP surgery.

Adipose tissue expression and regulation of UPR-related genes
The expression of UPR induced genes in subcutaneous abdominal adipose tissue was evaluated
in all 11 subjects before and 1 year after GBP surgery. We first examined the splicing of the
XBP-1 gene, a critical transcription factor and indicator of ER stress and adaptive responses.

Following GBP, there was an average 47.5% reduction (p=0.04) in spliced XBP-1 mRNA
compared to levels in pre-GBP tissues (Figure 2C). When examined individually, sXBP-1 levels
were decreased in 9 of the 11 subjects (Figure 2A,B). Next, we examined the expression of
GRP78 mRNA as this chaperone can be targeted by sXBP-1 and also by ATF-6, the second
transcription factor regulating UPR. As seen in Figure 3, the levels of Grp78 mRNA were
significantly decreased in post-GBP tissues, with an average 40.1% reduction in mRNA postGBP (p=0.01). When examined individually, decreased Grp78 gene expression was evident in
7/11 subjects (Figure 3A,B) suggesting that its regulation may be greater in variability than
sXBP-1. In contrast, adipose tissue CHOP expression was not significantly different between the
samples collected before or after surgery (Figure 4). Interestingly, in rodent models of obesity,
we also did not detect a significant regulation of CHOP mRNA expression between lean and
obese WAT (unpublished results). Adipose tissue IL-6 expression was determined in order to
compare the UPR changes to a well-established inflammatory alteration. Earlier studies have
shown that IL-6 expression is significantly and consistently down-regulated in adipose tissue
after weight loss [17-21]. Consistent with these observations, IL-6 mRNA levels were also
significantly reduced in 8/11 subjects following GBP (Figure 4).

Regulation of biochemical markers of ER stress in adipose and liver
The presence of tissue ER stress in obesity in rodents is best evaluated by the phosphorylation of
PERK, IRE-1, or eIF2 and stimulation of JNK activity, as these are more proximal measures of
UPR activity [7]. Since there are no antibodies that can detect the phosphorylated form of PERK
or IRE-1 in humans yet, we first measured the phosporylated form of eIF2

in adipose tissue

before and after GBP. Figure 5 reveals the presence of robust eIF2 phosphorylation in adipose

tissue in all obese subjects. Remarkably, there was a significant reduction in the phosphorylation
of adipose tissue eIF2

after GBP surgery, which was observed in all of the subjects studied

(p<0.0001). We also examined the activity of JNK, which can be activated through the IRE-1
branch of the UPR during ER stress. JNK activation, as determined by phosphorylation of the
JNK1 isoform, was detectable in the obese subjects prior to GBP surgery. As shown in Figure
5C, JNK phosphorylation also significantly decreased in adipose tissue post-GBP surgery. Taken
together, these observations indicate alleviation of ER stress in adipose tissue after substantial
weight loss.

In a subgroup of 4 subjects, liver biopsy samples were obtained before and 1 year after GBP
surgery.

H&E staining of the liver sections demonstrated a 90% decrease in intrahepatic

triglyceride content following GBP surgery (Table 1 and Figure 6A). In these limited number of
samples, we were also able to examine the effects of weight loss on eIF2 phosphorylation and
GRP78 protein levels by immunohistochemistry. Immunostaining with an anti-phospho eIF2
antibody revealed strong immunoreactivity in liver sections obtained prior to GBP (Figure 6).
Similarly, immunostaining with an antibody against the ER chaperone GRP78 revealed strong
staining in the obese subjects prior to GBP. Particularly, areas surrounding the lipid droplets
revealed intense staining. In the samples obtained after weight loss, immunoreactivity against
both phospho-eIF2 and GRP78 was reduced either in general intensity or number of areas. In
some cases the signal was reduced markedly (Figure 6 and Supplemental Figure 1) and in others
partially and with residual and scattered signal. Although variable among subjects, these results
indicate that similar to adipose tissue, obesity in humans may also be associated with ER stress
in liver tissue, which is ameliorated upon weight loss.

Discussion

Recent data from studies conducted in obese rodent models have demonstrated that ER stress and
the activation of related stress signaling pathways may be an important mechanism underlying
insulin resistance and type 2 diabetes [5]. The results of the present study demonstrate that, in
obese humans, ER stress is present in adipose and liver tissues and is highly regulated by weight
loss induced by GBP surgery.

Gastric bypass surgery is the most commonly performed bariatric surgical procedure in the
United States and worldwide, and is an effective approach for achieving weight loss in obese
patients [1].

Weight loss induced by GBP surgery improves or completely resolves most

obesity-related medical complications and increases survival [24, 25]. We chose to investigate
ER stress in patients who had GBP surgery so that comparisons could be made within the same
individual before and after the metabolic improvements of extreme weight loss. This approach
has several important strengths. First, each individual served as his/her own control, which
removes confounding variables that may not necessarily be accounted for if the control group
were comprised of a different cohort.

Second, by measuring change over time within an

individual, we are able to capture the state of the ER in flux. This is important given the highly
dynamic nature of the ER, which adjusts its adaptive capacity to the condition of the cells as well
as to environmental and intrinsic stress signals, such as alterations in metabolism and body
weight. Given the fluctuating environment of the cell and the adaptive responses of the ER, a
solitary UPR molecule may not a reliable indicator of ER functional capacity. Therefore, we
measured multiple markers of ER stress to assess the different UPR pathways, ranging from

proximal biochemical activities of the sensors, to their substrates, to the downstream
transcriptional outcomes of target gene expression.

Our data clearly demonstrate a significant weight loss-induced regulation of ER stress, as
evidenced by the suppression of biochemical indicators of ER stress such as eIF2

and JNK

phosphorylation, and downregulation of UPR transcriptional arms via spliced XBP1 and Grp78.
Given a relatively small patient number, we observed a remarkably consistent effect of weight
loss on ER stress. It is interesting that despite marked suppression of eIF2 phosphorylation in
adipose tissue upon weight loss, there was no change in the levels of CHOP mRNA expression,
which is generally considered to be downstream of eIF2

phosphorylation. It is possible that

CHOP is regulated through other signals and does not respond to changes in body weight. In
fact, in our recent work in rodent models comparing adipose tissue samples obtained from
genetic and dietary models of obesity with lean controls, we did not observe any change in the
expression levels of CHOP mRNA (unpublished results). Nonetheless, our findings suggest that
all branches of the UPR are potentially regulated by obesity and weight loss in humans.

The mechanism responsible for weight loss-induced reduction in ER stress in our subjects is not
known. Potential factors may include the decrease in adipose and liver triglyceride content or
the decrease in systemic plasma insulin and glucose concentrations. Although it is unclear how
these factors influence ER stress, data from in vitro studies suggest that inflammation, reactive
oxygen species, saturated fatty acids, or hypoxia could also be involved. These signals have all
been shown to compromise ER folding capacity and/or induce ER stress in vitro and have also
been described in obese, insulin resistant tissues.
mechanisms/causes remain unknown.

Nonetheless, the in vivo physiological

Two recent studies utilizing lean and obese cohorts have demonstrated regulation of ER stress
markers.

Boden et al. reported an increase in ER stress proteins and gene expression in

subcutaneous adipose tissue in obese individuals compared to lean [22].

A second study

measured ER stress markers within a range of BMIs and found a significant positive correlation
with increasing BMI [23]. These data support the hypothesis that obesity leads to increased ER
stress in adipose tissue and complements our findings of the effect of weight loss on tissue stress.
Interestingly, recent studies have also provided evidence that ER stress pathways are activated in
pancreatic islets in type 2 diabetes and in atherosclerotic vascular lesions [26, 27]. While this is
a relatively young field, these observations have raised the possibility that ER dysfunction and
the resulting stress responses may be important components of chronic metabolic diseases in a
broader sense. The extent to which these pathways will be relevant to human metabolic diseases,
particularly obesity and type 2 diabetes, remains a critical but unanswered question.

In summary, the results from the present study demonstrate that human obesity is associated with
insulin resistance and ER stress in both adipose tissue and the liver. Weight loss decreases ER
stress and improves insulin sensitivity, suggesting the possibility that the ER is involved in
regulating insulin action in obese humans. These findings, while correlative, are consistent with
data from studies conducted in rodent models, which have found that obesity is associated with
ER stress, and that ameliorating ER stress improves insulin action. Therefore, the ER could be
an important new target for treating the metabolic complications of obesity.
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Table 1. Metabolic characteristics of subjects before and 1 year after gastric bypass surgery.
Before Surgery
n (M/F)

After Surgery

10 (2/8)

10 (2/8)

40.3 ± 2.3

41.3 ± 2.3

Weight (kg)

143.5 ± 9.44

87.6 ± 5.9*

BMI (kg/m2)

51.3 ± 3.0

31.4 ± 2.3*

Glucose (mg/dL)

98.5 ± 4.8

84.2 ± 2.2†

Insulin (mU/L)

18.7 ± 3.1

4.9 ± 0.8*

HOMA-IR

5.3 ± 0.9

1.6 ± 0.5†

Intrahepatic fat content (%)§

19.5 ± 5.2

1.9 ± 2.1*

Systolic blood pressure (mm/Hg)

132 ± 7

108 ± 5*

Diastolic blood pressure (mm/Hg)

74 ± 3

63 ± 4†

Total cholesterol (mg/dL)

160 ± 13

161 ± 9

LDL-cholesterol (mg/dL)

85 ± 10

79 ± 6

HDL-cholesterol (mg/dL)

48 ± 4

68 ± 5**

135 ± 19

72 ± 9†

Age

Triglyceride (mg/dL)

HOMA-IR= homeostasis model assessment of insulin resistance.
§

Data from 4 subjects.

Values are means ± SEM. Value significantly different from corresponding Before Surgery
value; *P< 0.001; **P< 0.01; †P< 0.05.

Figure Legends
Figure 1. Alterations in systemic insulin sensitivity in GBP subjects.
A.) Hepatic Insulin Sensitivity Index, calculated as the reciprocal of the product of basal glucose
production and insulin concentration, B.) insulin-stimulated glucose disposal, an index of
skeletal muscle insulin sensitivity assessed as the relative increase in glucose uptake during
insulin infusion, and C.) insulin-mediated suppression of palmitate rate of appearance (Ra) into
plasma, an index of adipose tissue insulin sensitivity assessed as the relative decrease in
palmitate Ra during insulin infusion in obese subjects before (black bars) and 1 year after (white
bars) gastric bypass (GBP) surgery. *Value significantly different from the Before GBP value,
*p <0.01, **p<0.001.
Figure 2. Regulation of spliced XBP-1 mRNA in GBP subjects.
Quantitative RT-PCR was performed on RNA isolated from adipose tissue of patients before
and after GBP surgery, n=11. A.) Percent change in sXBP-1 mRNA from pre-GBP to postGBP levels in each individual patient. B.) Pre and Post-GBP surgery levels of sXBP-1 mRNA
normalized to 18S ribosomal RNA. C.) Average mRNA levels for sXBP-1 in Pre and Post-GBP
surgery groups. Data indicates Mean +/- SEM. * indicates p<0.05.
Figure 3. Regulation of Grp78 mRNA in GBP subjects.
Quantitative RT-PCR was performed on RNA isolated from adipose tissue of patients before and
after GBP, n=11. A.) Percent change in Grp78 mRNA from pre-GBP levels in each individual
patient. B.) Pre and Post-GBP surgery levels of Grp78 mRNA normalized to 18S ribosomal
RNA. C.) Average mRNA levels for Grp78 in Pre and Post-GBP groups. Data indicates Mean
+/- SEM. * indicates p<0.02.
Figure 4. CHOP and IL-6 mRNA levels in GBP subjects.
Quantitative RT-PCR was performed on RNA isolated from adipose tissue of patients before and
after GBP, n=11. A.) Percent change in CHOP and IL-6 mRNA from pre GBP levels in each
individual patient. B.) Pre and Post-GBP levels of CHOP and IL-6 mRNA normalized to 18S
ribosomal RNA. C.) Average mRNA levels for CHOP and IL-6 in Pre and Post-GBP groups.
Data indicates Mean +/- SEM. * indicates p<0.05.
Figure 5. Adipose tissue p-eIF2α and p-JNK levels after GBP procedure.
Protein expression levels of p-eIF2α and p-JNK in adipose tissue from patients before and after
GBP were detected by western blot assay, followed by densitometric analysis. A.) Pre and PostGBP levels of p-eIF2α and p-JNK normalized to calnexin. B.) Average levels of p-eIF2α and pJNK in Pre and Post-GBP groups. C.) Immunoblot analyses of p-eIF2α and p-JNK expression
levels in patient 67, 68 and 71 before and after GBP. Data indicates Mean +/- SEM. * indicates
p<0.05.
Figure 6. Liver histology and p-eIF2α and GRP78 immunoreactivity after GBP.
Liver tissue sections from patient #67 obtained during and after gastric bypass surgery (GBP)
were stained with H&E or with antibodies against p-eIF2 (green) or GRP78 (red). Nuclei are

stained with DAPI (blue). The upper panel illustrates severe steatosis in the pre-GBP sample and
marked reduction after GBP. Staining is particularly dense around the lipid droplets (appear
black in the stained samples). Quantification of staining is presented as relative intensity of
signal in before and after GBP sections. *p <0.01
Supplemental Figure. Liver tissue sections obtained from three additional subjects during and
after gastric bypass surgery (GBP) were stained with H&E or with antibodies against p-eIF2
(green) or GRP78 (red). The upper panel illustrates steatosis in the pre- GBP sample and marked
reduction after GBP. Staining is particularly dense around the lipid droplets (appear black in the
stained samples). Representative areas are shown for each of the samples. Quantification of
staining is presented as relative intensity of signal in before and after GBP sections. *p <0.01

